Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

18.06.2019 | short review | Ausgabe 2/2019 Open Access

memo - Magazine of European Medical Oncology 2/2019

Lung cancer screening—the surgeon’s perspective

memo - Magazine of European Medical Oncology > Ausgabe 2/2019
Caecilia Ng, Herbert Maier, MD Florian Augustin
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Results from lung cancer screening trials are promising and show improved survival of lung cancer patients, mainly due to a shift in tumor stages at the time of detection. More lung nodules for histopathologic workup and earlier tumor stages translate into more patients and work load for thoracic surgical units. This article provides a view on lung cancer screening from a thoracic surgeon’s perspective.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 2/2019

memo - Magazine of European Medical Oncology 2/2019 Zur Ausgabe